Business Resources

The Canadian Arthritis Network (CAN) offers a wide range of resources to entrepreneurs, innovators, decision makes, pharmaceutical and biotechnology companies as well as opportunities for partnerships in research and knowledge transfer.

Consulting and Laboratory Services

The Network's nearly 200 investigators are world-leading Canadian scientists with a wide range of skills and expertise in genetics and genomics, proteomics, inflammation, cellular and molecular biology of joint tissues, bioengineering for joint reconstruction, diagnostics and therapeutics, and methodologies and outcomes research. They offer consulting and product development services in the following areas:

• access to tissues and body fluids
• biomarkers
• biostatistics and bioinformatics
• cartilage and bone development
• epidemiology
• histology
• imaging techniques
• in vitro models of arthritis
• in vivo models of arthritis
• knock-out and transgenic animals
• mechanical loading and testing
• microarrays
• pathology
• pharmacology/pharmacokinetics
• proteomics

If you are interested in consulting or services in these or related areas, please contact Johnathan Riley at 416-586-3167.

Pre-clinical models of osteoarthritis

The pre-clinical resources program facilitates the translation of pre-clinical science to clinical science for industry. The Network's highly qualified experts can develop and implement protocols to evaluate drugs for clinical use or evaluate the mechanisms of action for drug candidates.

The Network offers in vivo diagnostics and screening systems for:

• biomarkers;
• prognostic and predictive indicators;
• imaging; and,
• in vitro screening.

In addition, the Network offers analytical services and expert consultants in protocol design, method evaluation, and review and analysis of data. New technologies are currently being developed to monitor disease activity and joint damage in vivo.

For more information, please click here.

Canadian Rheumatology Research Consortium

The Canadian Rheumatology Research Consortium (CRRC), established with the support of the Network to conduct clinical trials in new therapies for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, lupus and psoriatic arthritis, is the first national clinical trials research program of its kind in arthritis. It completes the continuum of services offered by the Network from bench to bedside to the community. The CRRC conducts clinical trials; offers centralized site selection and budget negotiation; and consulting in clinical development, particularly in trial design and evaluation. For more information please visit www.rheumtrials.ca or contact Linda Bennett at 416-586-5912.

Return to top